Abstract
To diagnose Lyme Borreliosis, it is advised to use an enzyme-linked immunosorbent test to check for serum antibodies specific for Lyme and all tests with positive or ambiguous enzyme-linked immunosorbent assay (ELISA) results being confirmed by immunoblot. This method of measuring the humoral immunity in human fluids (e.g., by ELISA) has provided robust and reproducible results for decades and similar assays have been validated for monitoring of B cell immunity. These immunological tests that detect antibodies to Borrelia burgdorferi are useful in the diagnosis of Borreliosis on a routine basis. The variety of different Borrelia species and their different geographic distributions are the main reasons why standards and recommendations are not identical across all geographic regions of the world. In contrast to humoral immunity, the T cell reaction or cellular immunity to the Borrelia infection has not been well elucidated, but over time with more studies a novel T cell-based assay (EliSpot) has been developed and validated for the sensitive detection of antigen-specific T cell responses to B. burgdorferi. The EliSpot Lyme assay can be used to study the T cell response elicited by Borrelia infections, which bridges the gap between the ability to detect humoral immunity and cellular immunity in Lyme disease. In addition, detecting cellular immunity may be a helpful laboratory diagnostic test for Lyme disease, especially for seronegative Lyme patients. Since serodiagnostic methods of the Borrelia infection frequently provide false positive and negative results, this T cell-based diagnostic test (cellular assay) may help in confirming a Lyme diagnosis. Many clinical laboratories are convinced that the cellular assay is superior to the Western Blot assay in terms of sensitivity for detecting the underlying Borrelia infection. Research also suggests that there is a dissociation between the magnitude of the humoral and the T cell-mediated cellular immune responses in the Borrelia infection. Lastly, the data implies that the EliSpot Lyme assay may be helpful to identify Borrelia infected individuals when the serology-based diagnostic fails to do so. Here in this chapter the pairing of humoral and cellular immunity is employed to evaluate the adaptive response in patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bauer Y, Hofmann H, Jahraus O et al (2001) Prominent T cell response to a selectively in vivo expressed Borrelia burgdorferi outer surface protein (pG) in patients with Lyme disease. Eur J Immunol 31(3):767–776. https://doi.org/10.1002/1521-4141(200103)31:3<767::aid-immu767>3.0.co;2-m
Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH Jr (2011) Updates on Borrelia burgdorferi sensu lato complex with respect to public health. Ticks Tick Borne Dis 2(3):123–128. https://doi.org/10.1016/j.ttbdis.2011.04.002
B. miyamotoi. CDC. Accessed 30 June 2023. https://www.cdc.gov/relapsing-fever/miyamotoi/index.htmL
WHO Regional Office for Europe, European Centre for Disease Prevention and Control (2021) Climate-ADAPT. 25 Jun 2021
Kugeler KJ, Schwartz AM, Delorey MJ et al (2021) Estimating the frequency of Lyme disease diagnoses, United States, 2010–2018. Emerg Infect Dis 27(2):616–619. https://doi.org/10.3201/eid2702.202731
van Gorkom T, Voet W, Sankatsing SUC et al (2020) Prospective comparison of two enzyme-linked immunosorbent spot assays for the diagnosis of Lyme Neuroborreliosis. Clin Exp Immunol 199(3):337–356. https://doi.org/10.1111/cei.13393
Eldin C, Parola P, Raoult D (2019) Limitations of diagnostic tests for bacterial infections. Med Mal Infect 49(2):98–101. https://doi.org/10.1016/j.medmal.2018.12.004
Alberts B, Johnson A, Lewis J et al (2002) Helper T cells and lymphocyte activation, Molecular biology of the cell, 4th edn. Garland Science, New York
Jin C, Roen DR, Lehmann PV, Kellermann GH (2013) An enhanced ELISPOT assay for sensitive detection of antigen-specific T cell responses to Borrelia burgdorferi. Cells 2(3):607–620. https://doi.org/10.3390/cells2030607
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Pruteanu, M., Schwarzbach, A., Berger, M. (2024). Adaptive Immune Response Investigation in Lyme Borreliosis. In: Gilbert, L. (eds) Borrelia burgdorferi. Methods in Molecular Biology, vol 2742. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3561-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3561-2_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3560-5
Online ISBN: 978-1-0716-3561-2
eBook Packages: Springer Protocols